本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Solid Biosciences

8.91
+0.04000.45%
盤後8.910.00000.00%19:30 EDT
成交量:409.06萬
成交額:3,634.39萬
市值:9.55億
市盈率:-4.76
高:8.97
開:8.87
低:8.64
收:8.87
52周最高:11.45
52周最低:3.79
股本:1.07億
流通股本:6,481.19萬
量比:2.88
換手率:6.31%
股息:- -
股息率:- -
每股收益(TTM):-1.8709
每股收益(LYR):-1.9922
淨資產收益率:-65.50%
總資產收益率:-36.38%
市淨率:2.55
市盈率(LYR):-4.47

資料載入中...

2024/02/06

SEC問詢函

Form CORRESP - Correspondence
2024/01/23

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/12

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/12

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/09

重要事件披露

Form 8-K - Current report
2023/06/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/23

重要事件披露

Form 8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/20

重要事件披露

8-K - Current report
2023/03/13

重要事件披露

8-K - Current report
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals